VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $23.43 million. The enterprise value is -$36.21 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, before market open.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 14.83 million shares outstanding. The number of shares has increased by 314.57% in one year.
| Current Share Class | 14.83M |
| Shares Outstanding | 14.83M |
| Shares Change (YoY) | +314.57% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 34.65% |
| Float | 10.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 144.52 |
| Forward PS | 82.39 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.35, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.35 |
| Quick Ratio | 4.15 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.54% and return on invested capital (ROIC) is -38.65%.
| Return on Equity (ROE) | -56.54% |
| Return on Assets (ROA) | -33.14% |
| Return on Invested Capital (ROIC) | -38.65% |
| Return on Capital Employed (ROCE) | -83.78% |
| Revenue Per Employee | $38,538 |
| Profits Per Employee | -$3.06M |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VYNE has paid $4,000 in taxes.
| Income Tax | 4,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.53% in the last 52 weeks. The beta is 1.25, so VYNE's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -48.53% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 27.29 |
| Average Volume (20 Days) | 192,539 |
Short Selling Information
The latest short interest is 150,482, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 150,482 |
| Short Previous Month | 123,785 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.40% |
| Short Ratio (days to cover) | 1.23 |
Income Statement
In the last 12 months, VYNE had revenue of $501,000 and -$39.83 million in losses. Loss per share was -$0.94.
| Revenue | 501,000 |
| Gross Profit | 501,000 |
| Operating Income | -43.64M |
| Pretax Income | -29.08M |
| Net Income | -39.83M |
| EBITDA | -43.63M |
| EBIT | -43.64M |
| Loss Per Share | -$0.94 |
Full Income StatementBalance Sheet
The company has $61.52 million in cash and $99,000 in debt, giving a net cash position of $61.42 million or $4.14 per share.
| Cash & Cash Equivalents | 61.52M |
| Total Debt | 99,000 |
| Net Cash | 61.42M |
| Net Cash Per Share | $4.14 |
| Equity (Book Value) | 52.09M |
| Book Value Per Share | 3.51 |
| Working Capital | 49.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.97 million and capital expenditures -$117,000, giving a free cash flow of -$34.09 million.
| Operating Cash Flow | -33.97M |
| Capital Expenditures | -117,000 |
| Free Cash Flow | -34.09M |
| FCF Per Share | -$2.30 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -8,709.98% |
| Pretax Margin | -7,944.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -314.57% |
| Shareholder Yield | n/a |
| Earnings Yield | -158.00% |
| FCF Yield | -135.21% |
Analyst Forecast
The average price target for VYNE is $6.88, which is 335.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.88 |
| Price Target Difference | 335.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 129.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.0555556:1.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0555556:1 |
Scores
VYNE has an Altman Z-Score of -15.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.22 |
| Piotroski F-Score | 2 |